Apotex Asks Justices To Make Fed. Circ. Use Less 'Rigid' Test

By Britain Eakin (December 17, 2021, 9:07 PM EST) -- Apotex Inc. has asked the Supreme Court to reverse a Federal Circuit ruling affirming that it infringed patents for Eagle Pharmaceuticals' cancer drug Bendeka, saying Eagle just reformulated an old drug developed in East Germany in the 1960s, so the patents should have been found obvious.

In a Dec. 14 petition for certiorari docketed Thursday, Apotex said the Federal Circuit's August decision, which summarily affirmed a district court's finding that its planned generic of Bendeka infringed Eagle's patents, "strayed" from the Supreme Court's 2007 decision in KSR International Co. v. Teleflex Inc.

KSR held that the Federal Circuit was using an...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!